SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe

We conducted a severe acute respiratory syndrome coronavirus 2 antibody seroprevalence study among >2,000 domestic cats from 4 countries during the first coronavirus disease wave in Europe. We found 4.4% seroprevalence using a virus neutralization test and 4.3% using a receptor-binding domain ELI...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulz, Claudia, Martina, Byron, Mirolo, Monica, Müller, Elisabeth, Klein, Ruth, Volk, Holger, Egberink, Herman, Gonzalez-Hernandez, Mariana, Kaiser, Franziska, von Köckritz-Blickwede, Maren, Osterhaus, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632155/
https://www.ncbi.nlm.nih.gov/pubmed/34695368
http://dx.doi.org/10.3201/eid2712.211252
_version_ 1784607699917340672
author Schulz, Claudia
Martina, Byron
Mirolo, Monica
Müller, Elisabeth
Klein, Ruth
Volk, Holger
Egberink, Herman
Gonzalez-Hernandez, Mariana
Kaiser, Franziska
von Köckritz-Blickwede, Maren
Osterhaus, Albert
author_facet Schulz, Claudia
Martina, Byron
Mirolo, Monica
Müller, Elisabeth
Klein, Ruth
Volk, Holger
Egberink, Herman
Gonzalez-Hernandez, Mariana
Kaiser, Franziska
von Köckritz-Blickwede, Maren
Osterhaus, Albert
author_sort Schulz, Claudia
collection PubMed
description We conducted a severe acute respiratory syndrome coronavirus 2 antibody seroprevalence study among >2,000 domestic cats from 4 countries during the first coronavirus disease wave in Europe. We found 4.4% seroprevalence using a virus neutralization test and 4.3% using a receptor-binding domain ELISA, demonstrating probable human-to-cat transmission.
format Online
Article
Text
id pubmed-8632155
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-86321552021-12-01 SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe Schulz, Claudia Martina, Byron Mirolo, Monica Müller, Elisabeth Klein, Ruth Volk, Holger Egberink, Herman Gonzalez-Hernandez, Mariana Kaiser, Franziska von Köckritz-Blickwede, Maren Osterhaus, Albert Emerg Infect Dis Dispatch We conducted a severe acute respiratory syndrome coronavirus 2 antibody seroprevalence study among >2,000 domestic cats from 4 countries during the first coronavirus disease wave in Europe. We found 4.4% seroprevalence using a virus neutralization test and 4.3% using a receptor-binding domain ELISA, demonstrating probable human-to-cat transmission. Centers for Disease Control and Prevention 2021-12 /pmc/articles/PMC8632155/ /pubmed/34695368 http://dx.doi.org/10.3201/eid2712.211252 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Schulz, Claudia
Martina, Byron
Mirolo, Monica
Müller, Elisabeth
Klein, Ruth
Volk, Holger
Egberink, Herman
Gonzalez-Hernandez, Mariana
Kaiser, Franziska
von Köckritz-Blickwede, Maren
Osterhaus, Albert
SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe
title SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe
title_full SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe
title_fullStr SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe
title_full_unstemmed SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe
title_short SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe
title_sort sars-cov-2–specific antibodies in domestic cats during first covid-19 wave, europe
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632155/
https://www.ncbi.nlm.nih.gov/pubmed/34695368
http://dx.doi.org/10.3201/eid2712.211252
work_keys_str_mv AT schulzclaudia sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope
AT martinabyron sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope
AT mirolomonica sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope
AT mullerelisabeth sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope
AT kleinruth sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope
AT volkholger sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope
AT egberinkherman sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope
AT gonzalezhernandezmariana sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope
AT kaiserfranziska sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope
AT vonkockritzblickwedemaren sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope
AT osterhausalbert sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope

Ejemplares similares